| 1 | Retrospective evaluation of a <scp>TEN</scp>/<scp>SJS</scp> series managed with a new treatment protocol | 2.6 | 0 | Citations (PDF) |
| 2 | Development of a 43 color panel for the characterization of conventional and unconventional T‐cell subsets, B cells, <scp>NK</scp> cells, monocytes, dendritic cells, and innate lymphoid cells using spectral flow cytometry | 2.7 | 38 | Citations (PDF) |
| 3 | Successful treatment of pachyonychia congenita with simvastatin | 2.6 | 0 | Citations (PDF) |
| 4 | Flushing New Light on Rosacea | 0.7 | 0 | Citations (PDF) |
| 5 | Editorial: Itch treatments | 2.7 | 0 | Citations (PDF) |
| 6 | Severe atopic dermatitis in an Asian‐Arabic population treated with dupilumab: A retrospective observational study | 2.6 | 0 | Citations (PDF) |
| 7 | Recalcitrant pityriasis rubra pilaris in a Middle Eastern patient and arguments for early anti‐IL‐23 targeting | 0.5 | 0 | Citations (PDF) |
| 8 | Metabolomics analyses reveal the crucial role of <scp>ERK</scp> in regulating metabolic pathways associated with the proliferation of human cutaneous T‐cell lymphoma cells treated with Glabridin | 5.9 | 2 | Citations (PDF) |
| 9 | Combining treat‐to‐target principles and shared decision‐making: International expert consensus‐based recommendations with a novel concept for minimal disease activity criteria in atopic dermatitis | 2.6 | 6 | Citations (PDF) |
| 10 | Impact of Previous Alopecia Areata Treatment on Efficacy Responses up to Week 48 Following Ritlecitinib Treatment: A Post Hoc Analysis | 3.7 | 0 | Citations (PDF) |
| 11 | Interleukin-31: The Inflammatory Cytokine Connecting Pruritus and Cancer | 2.7 | 0 | Citations (PDF) |
| 12 | Successful treatment of rare linear lichen planopilaris with Ixekizumab | 2.9 | 3 | Citations (PDF) |
| 13 | Dupilumab in prurigo nodularis: a systematic review of current evidence and analysis of predictive factors to response | 2.9 | 41 | Citations (PDF) |
| 14 | Role of non-coding RNAs in the progression and resistance of cutaneous malignancies and autoimmune diseases | 14.2 | 22 | Citations (PDF) |
| 15 | Effectiveness of ustekinumab in patients with atopic dermatitis: analysis of real-world evidence | 2.9 | 9 | Citations (PDF) |
| 16 | Efficacy and predictive factors of cyclosporine A in alopecia areata: a systematic review with meta-analysis | 2.9 | 11 | Citations (PDF) |
| 17 | Molecular pathogenesis of Cutaneous T cell Lymphoma: Role of chemokines, cytokines, and dysregulated signaling pathways | 14.2 | 33 | Citations (PDF) |
| 18 | Neuroimmune communication regulating pruritus in atopic dermatitis | 2.8 | 72 | Citations (PDF) |
| 19 | Epigenetic regulation of CXCR4 signaling in cancer pathogenesis and progression | 14.2 | 24 | Citations (PDF) |
| 20 | Recalcitrant erythrodermic ichthyosis with atopic dermatitis successfully treated with Dupilumab in combination with Guselkumab | 1.4 | 9 | Citations (PDF) |
| 21 | Molecular and cellular mechanisms of itch and pain in atopic dermatitis and implications for novel therapeutics | 3.7 | 33 | Citations (PDF) |
| 22 | IL‐20 promotes cutaneous inflammation and peripheral itch sensation in atopic dermatitis | 0.7 | 7 | Citations (PDF) |
| 23 | Potential role of INTERLEUKIN‐17 in the pathogenesis of oral lichen planus: a systematic review with META‐analysis | 2.6 | 21 | Citations (PDF) |
| 24 | The PLAUR signaling promotes chronic pruritus | 0.7 | 12 | Citations (PDF) |
| 25 | Bullous pemphigoid induced by biologic drugs in psoriasis: a systematic review | 2.9 | 16 | Citations (PDF) |
| 26 | Evaluation of the efficacy of subantimicrobial dose doxycycline in rosacea: a systematic review of clinical trials and meta‐analysis | 0.6 | 6 | Citations (PDF) |
| 27 | Mouse models of atopic dermatitis: a critical reappraisal | 2.8 | 46 | Citations (PDF) |
| 28 | Prevalence, pathophysiology and management of itch in epidermolysis bullosa* | 2.0 | 47 | Citations (PDF) |
| 29 | Laser and light-based therapies in the management of rosacea: an updated systematic review | 2.2 | 11 | Citations (PDF) |
| 30 | Bewertung der Wirksamkeit sub‐antimikrobieller Dosierungen von Doxycyclin bei Rosacea: Systematische Auswertung von klinischen Studien und Metaanalyse | 0.6 | 0 | Citations (PDF) |
| 31 | Neurokinin 1 Receptor Antagonists for Pruritus | 12.1 | 12 | Citations (PDF) |
| 32 | Interleukin‐31: The “itchy” cytokine in inflammation and therapy | 7.6 | 125 | Citations (PDF) |
| 33 | Th2 Modulation of Transient Receptor Potential Channels: An Unmet Therapeutic Intervention for Atopic Dermatitis | 5.0 | 65 | Citations (PDF) |
| 34 | In vitro Interleukin-7 treatment partially rescues MAIT cell dysfunction caused by SARS-CoV-2 infection | 3.7 | 10 | Citations (PDF) |
| 35 | F-box proteins in cancer stemness: An emerging prognostic and therapeutic target | 7.2 | 12 | Citations (PDF) |
| 36 | Comparative appraisal with meta‐analysis of erbium vs. CO<sub>2</sub>lasers for atrophic acne scars | 0.6 | 15 | Citations (PDF) |
| 37 | Treatment and molecular profiling of acrodermatitis continua of Hallopeau during pregnancy using targeted therapy | 0.9 | 1 | Citations (PDF) |
| 38 | Innate immune regulates cutaneous sensory IL-13 receptor alpha 2 to promote atopic dermatitis | 4.3 | 19 | Citations (PDF) |
| 39 | Sanguinarine mediated apoptosis in Non-Small Cell Lung Cancer via generation of reactive oxygen species and suppression of JAK/STAT pathway | 6.7 | 34 | Citations (PDF) |
| 40 | Vergleichende Metaanalyse zur Behandlung atropher Aknenarben mit Erbium‐Laser versus CO<sub>2</sub>‐Laser | 0.6 | 2 | Citations (PDF) |
| 41 | The effect of migration on the incidence of new-onset metabolic syndrome in migrants to Qatar | 0.3 | 0 | Citations (PDF) |
| 42 | Characterizing high-burden rosacea subjects: a multivariate risk factor analysis from a global survey | 2.9 | 13 | Citations (PDF) |
| 43 | Efficacy of topical ivermectin and impact on quality of life in patients with papulopustular rosacea: A systematic review and meta‐analysis | 1.8 | 16 | Citations (PDF) |
| 44 | <p>The Unmet Need for Clinical Guidelines on the Management of Patients with Plaque Psoriasis in Africa and the Middle East</p> | 3.5 | 1 | Citations (PDF) |
| 45 | Dysregulated Phosphorylation of p53, Autophagy and Stemness Attributes the Mutant p53 Harboring Colon Cancer Cells Impaired Sensitivity to Oxaliplatin | 2.7 | 17 | Citations (PDF) |
| 46 | Protease-Activated Receptor-2 Regulates Neuro-Epidermal Communication in Atopic Dermatitis | 5.0 | 55 | Citations (PDF) |
| 47 | Erythrodermie und hypernatriämische Dehydratation beim
Neugeborenen – eine Fallbeschreibung des
Netherton-Syndroms | 0.6 | 0 | Citations (PDF) |
| 48 | TRPV2: A Cancer Biomarker and Potential Therapeutic Target | 1.7 | 49 | Citations (PDF) |
| 49 | Exosomes: Emerging Diagnostic and Therapeutic Targets in Cutaneous Diseases | 4.5 | 34 | Citations (PDF) |
| 50 | CAR-T Cell Therapies: An Overview of Clinical Studies Supporting Their Approved Use against Acute Lymphoblastic Leukemia and Large B-Cell Lymphomas | 4.5 | 58 | Citations (PDF) |
| 51 | EGFR/Ras-induced CCL20 production modulates the tumour microenvironment | 5.7 | 22 | Citations (PDF) |
| 52 | Non-Coding RNAs as Regulators and Markers for Targeting of Breast Cancer and Cancer Stem Cells | 4.0 | 32 | Citations (PDF) |
| 53 | Curcumin-Mediated Apoptotic Cell Death in Papillary Thyroid Cancer and Cancer Stem-Like Cells through Targeting of the JAK/STAT3 Signaling Pathway | 4.5 | 70 | Citations (PDF) |
| 54 | Role of neuroimmune circuits and pruritus in psoriasis | 2.8 | 43 | Citations (PDF) |
| 55 | Effects of skin care habits on the development of rosacea: A multi-center retrospective case-control survey in Chinese population | 2.5 | 18 | Citations (PDF) |
| 56 | Curcumin Induces Apoptotic Cell Death via Inhibition of PI3-Kinase/AKT Pathway in B-Precursor Acute Lymphoblastic Leukemia | 2.7 | 67 | Citations (PDF) |
| 57 | House dust mite‐treated PAR2 over‐expressor mouse: A novel model of atopic dermatitis | 2.8 | 20 | Citations (PDF) |
| 58 | Interleukin‐4 and interleukin‐13 evoke scratching behaviour in mice | 2.8 | 86 | Citations (PDF) |
| 59 | Role of miRNA-Regulated Cancer Stem Cells in the Pathogenesis of Human Malignancies | 4.8 | 227 | Citations (PDF) |
| 60 | Protein Expression Profiling Identifies Key Proteins and Pathways Involved in Growth Inhibitory Effects Exerted by Guggulsterone in Human Colorectal Cancer Cells | 4.0 | 15 | Citations (PDF) |
| 61 | Role of SNAREs in Atopic Dermatitis–Related Cytokine Secretion and Skin-Nerve Communication | 0.7 | 21 | Citations (PDF) |
| 62 | TLR3 in Chronic Human Itch: A Keratinocyte-Associated Mechanism of Peripheral Itch Sensitization | 0.7 | 24 | Citations (PDF) |
| 63 | The Role of Extracellular Vesicles as Modulators of the Tumor Microenvironment, Metastasis and Drug Resistance in Colorectal Cancer | 4.0 | 45 | Citations (PDF) |
| 64 | Sanguinarine Induces Apoptosis Pathway in Multiple Myeloma Cell Lines via Inhibition of the JaK2/STAT3 Signaling | 2.7 | 37 | Citations (PDF) |
| 65 | Understanding the Burden of Atopic Dermatitis in Africa and the Middle East | 3.7 | 33 | Citations (PDF) |
| 66 | Evaluation of cationic channel TRPV2 as a novel biomarker and therapeutic target in Leukemia-Implications concerning the resolution of pulmonary inflammation | 3.7 | 18 | Citations (PDF) |
| 67 | Greensporone A, a Fungal Secondary Metabolite Suppressed Constitutively Activated AKT via ROS Generation and Induced Apoptosis in Leukemic Cell Lines | 4.4 | 16 | Citations (PDF) |
| 68 | Neuropathic itch | 4.6 | 29 | Citations (PDF) |
| 69 | Pharmacologic inhibition of hypoxia‐inducible factor (HIF)‐hydroxylases ameliorates allergic contact dermatitis | 7.6 | 16 | Citations (PDF) |
| 70 | Serlopitant for the treatment of chronic pruritus: Results of a randomized, multicenter, placebo-controlled phase 2 clinical trial | 1.3 | 90 | Citations (PDF) |
| 71 | New mechanism underlying IL-31–induced atopic dermatitis | 2.8 | 134 | Citations (PDF) |
| 72 | Role of mast cells and basophils in pruritus | 6.8 | 62 | Citations (PDF) |
| 73 | Rosacea comorbidities and future research: The 2017 update by the National Rosacea Society Expert Committee | 1.3 | 31 | Citations (PDF) |
| 74 | Standard classification and pathophysiology of rosacea: The 2017 update by the National Rosacea Society Expert Committee | 1.3 | 317 | Citations (PDF) |
| 75 | Mast cells are critical for the limitation of thrombin‐induced skin inflammation | 2.8 | 10 | Citations (PDF) |
| 76 | Recent advances in understanding and managing rosacea | 0.6 | 116 | Citations (PDF) |
| 77 | Impact of Ixekizumab Treatment on Itch and Psoriasis Area and Severity Index in Patients with Moderate-to-Severe Plaque Psoriasis: An Integrated Analysis of Two Phase III Randomized Studies | 3.7 | 16 | Citations (PDF) |
| 78 | Clinical presentation, management, and pathophysiology of neuropathic itch | 19.1 | 74 | Citations (PDF) |
| 79 | Emerging strategies for the diagnosis and treatment of meibomian gland dysfunction: Proceedings of the OCEAN group meeting | 4.2 | 116 | Citations (PDF) |
| 80 | Synergistic antipruritic effects of gamma aminobutyric acid A and B agonists in a mouse model of atopic dermatitis | 2.8 | 33 | Citations (PDF) |
| 81 | <scp>FRT</scp> – FONDATION RENE TOURAINE | 2.8 | 0 | Citations (PDF) |
| 82 | Integrative concepts of rosacea pathophysiology, clinical presentation and new therapeutics | 2.8 | 132 | Citations (PDF) |
| 83 | Involvement of TRPV1 and TDAG8 in Pruriception Associated with Noxious Acidosis | 0.7 | 19 | Citations (PDF) |
| 84 | Tumor–Endothelial Cross-Talk 2017, , 4696-4698 | | 0 | Citations (PDF) |
| 85 | Topical Immune Response Modifiers: Antiinflammatories 2017, , 791-802 | | 0 | Citations (PDF) |
| 86 | Facial Erythema of Rosacea – Aetiology, Different Pathophysiologies and Treatment Options | 2.0 | 63 | Citations (PDF) |
| 87 | New light on proteases regulating pigmentation | 2.8 | 5 | Citations (PDF) |
| 88 | The pruritus- and TH2-associated cytokine IL-31 promotes growth of sensory nerves | 2.8 | 207 | Citations (PDF) |
| 89 | Topical Ivermectin 10 mg/g and Oral Doxycycline 40 mg Modified-Release: Current Evidence on the Complementary Use of Anti-Inflammatory Rosacea Treatments | 3.4 | 31 | Citations (PDF) |
| 90 | Multidisciplinary Consideration of Potential Pathophysiologic Mechanisms of Paradoxical Erythema with Topical Brimonidine Therapy | 3.4 | 13 | Citations (PDF) |
| 91 | TNFα induces co-trafficking of TRPV1/TRPA1 in VAMP1-containing vesicles to the plasmalemma via Munc18–1/syntaxin1/SNAP-25 mediated fusion | 3.7 | 97 | Citations (PDF) |
| 92 | Molecular mechanisms of pruritus | 1.8 | 39 | Citations (PDF) |
| 93 | Involvement of TRPV4 in Serotonin-Evoked Scratching | 0.7 | 115 | Citations (PDF) |
| 94 | Role of TRP Channels in Skin Diseases 2015, , 293-323 | | 4 | Citations (PDF) |
| 95 | Pituitary Adenylate Cyclase-Activating Polypeptide Is Upregulated in Murine Skin Inflammation and Mediates Transient Receptor Potential Vanilloid-1-Induced Neurogenic Edema | 0.7 | 17 | Citations (PDF) |
| 96 | Molecular and Morphological Characterization of Inflammatory Infiltrate in Rosacea Reveals Activation of Th1/Th17 Pathways | 0.7 | 203 | Citations (PDF) |
| 97 | Role of Cytokines and Chemokines in Itch | 0.0 | 45 | Citations (PDF) |
| 98 | Tumor–Endothelial Cross-Talk 2015, , 1-3 | | 0 | Citations (PDF) |
| 99 | Keratinocyte Growth Regulation TRP-ed Up Over Downregulated TRPV4? | 0.7 | 5 | Citations (PDF) |
| 100 | A sensory neuron–expressed IL-31 receptor mediates T helper cell–dependent itch: Involvement of TRPV1 and TRPA1 | 2.8 | 574 | Citations (PDF) |
| 101 | B Cells Regulate Macrophage Phenotype and Response to Chemotherapy in Squamous Carcinomas | 33.4 | 247 | Citations (PDF) |
| 102 | Neural peptidase endothelin-converting enzyme 1 regulates endothelin 1–induced pruritus | 9.1 | 80 | Citations (PDF) |
| 103 | Aktuelles Verständnis der Pathophysiologie der Rosazea | 0.9 | 6 | Citations (PDF) |
| 104 | Serum kallikrein-8 correlates with skin activity, but not psoriatic arthritis, in patients with psoriatic disease | 2.7 | 31 | Citations (PDF) |
| 105 | Rosacea and small intestinal bacterial overgrowth: Prevalence and response to rifaximin | 1.3 | 40 | Citations (PDF) |
| 106 | New insights into rosacea pathophysiology: A review of recent findings | 1.3 | 265 | Citations (PDF) |
| 107 | Understanding itch in skin disease | 1.4 | 1 | Citations (PDF) |
| 108 | Recapitulating Atopic Dermatitis in Three Dimensions: Cross Talk between Keratinocytes and Nerve Fibers | 0.7 | 11 | Citations (PDF) |
| 109 | UVB radiation generates sunburn pain and affects skin by activating epidermal TRPV4 ion channels and triggering endothelin-1 signaling | 7.7 | 207 | Citations (PDF) |
| 110 | Transient receptor potential ankyrin 1 mediates chronic pancreatitis pain in mice | 3.5 | 44 | Citations (PDF) |
| 111 | Proteinase-Activated Receptor-2 Agonist Activates Anti-Influenza Mechanisms and Modulates IFN<i>γ</i>-Induced Antiviral Pathways in Human Neutrophils | 2.7 | 11 | Citations (PDF) |
| 112 | The TGR5 receptor mediates bile acid–induced itch and analgesia | 9.1 | 293 | Citations (PDF) |
| 113 | Disseminated Erosive Pustular Dermatosis also Involving the Mucosa: Successful Treatment with Oral Dapsone | 2.0 | 14 | Citations (PDF) |
| 114 | Psychoneuroimmunology of Psychological Stress and Atopic Dermatitis: Pathophysiologic and Therapeutic Updates | 2.0 | 182 | Citations (PDF) |
| 115 | Mouse Model of Touch-Evoked Itch (Alloknesis) | 0.7 | 93 | Citations (PDF) |
| 116 | Proteinase-Activated Receptors 1 and 2 Regulate Invasive Behavior of Human Melanoma Cells via Activation of Protein Kinase D1 | 0.7 | 12 | Citations (PDF) |
| 117 | Distribution and Expression of Non-Neuronal Transient Receptor Potential (TRPV) Ion Channels in Rosacea | 0.7 | 169 | Citations (PDF) |
| 118 | α-1-Antitrypsin and IFN-γ Reduce the Severity of IC-Mediated Vasculitis by Regulation of Leukocyte Recruitment In Vivo | 0.7 | 8 | Citations (PDF) |
| 119 | PAR-2 Inhibition Reverses Experimental Pulmonary Hypertension | 12.8 | 57 | Citations (PDF) |
| 120 | Serine Protease Inhibition Reduces Post-Ischemic Granulocyte Recruitment in Mouse Intestine | 3.6 | 29 | Citations (PDF) |
| 121 | Evaluation and management of a patient with chronic pruritus | 2.8 | 20 | Citations (PDF) |
| 122 | IL-33: A Novel Danger Signal System in Atopic Dermatitis | 0.7 | 97 | Citations (PDF) |
| 123 | New tools for assessing the individual risk of metastasis in renal cell carcinoma | 2.9 | 4 | Citations (PDF) |
| 124 | Neurogenic Rosacea: A Distinct Clinical Subtype Requiring a Modified Approach to Treatment | 2.2 | 68 | Citations (PDF) |
| 125 | Clinical, Cellular, and Molecular Aspects in the Pathophysiology of Rosacea | 2.6 | 201 | Citations (PDF) |
| 126 | Pathophysiology of Rosacea: Introduction | 2.6 | 7 | Citations (PDF) |
| 127 | Anatomy and Neurophysiology of Pruritus | 1.3 | 51 | Citations (PDF) |
| 128 | Pruritus in Elderly Patients—Eruptions of Senescence | 1.3 | 92 | Citations (PDF) |
| 129 | Pruritus and Renal Failure | 1.3 | 43 | Citations (PDF) |
| 130 | Introduction | 1.3 | 2 | Citations (PDF) |
| 131 | Pruritus: Management Algorithms and Experimental Therapies | 1.3 | 52 | Citations (PDF) |
| 132 | Management of Itch in Atopic Dermatitis | 1.3 | 120 | Citations (PDF) |
| 133 | Role of Spinal Neurotransmitter Receptors in Itch: New Insights into Therapies and Drug Development | 5.1 | 56 | Citations (PDF) |
| 134 | The Distinct Roles of Two GPCRs, MrgprC11 and PAR2, in Itch and Hyperalgesia | 5.5 | 185 | Citations (PDF) |
| 135 | Role of proteinase‐activated receptor‐2 in anti‐bacterial and immunomodulatory effects of interferon‐γ on human neutrophils and monocytes | 4.8 | 13 | Citations (PDF) |
| 136 | Role of protease-activated receptors in human skin fibrosis and scleroderma | 2.8 | 13 | Citations (PDF) |
| 137 | Endothelin‐converting enzyme‐1 regulates trafficking and signalling of the neurokinin 1 receptor in endosomes of myenteric neurones | 3.2 | 30 | Citations (PDF) |
| 138 | Dissecting itch and pain sensations in human skinPain, 2011, 152, 2453-2454 | 4.6 | 4 | Citations (PDF) |
| 139 | Rosacea: the Cytokine and Chemokine Network | 2.6 | 124 | Citations (PDF) |
| 140 | PAR2 absence completely rescues inflammation and ichthyosis caused by altered CAP1/Prss8 expression in mouse skin | 14.1 | 89 | Citations (PDF) |
| 141 | Neurovascular and Neuroimmune Aspects in the Pathophysiology of Rosacea | 2.6 | 201 | Citations (PDF) |
| 142 | Protein phosphatase 2A mediates resensitization of the neurokinin 1 receptor | 4.4 | 21 | Citations (PDF) |
| 143 | Tumor–Endothelial Cross-talk 2011, , 3813-3815 | | 0 | Citations (PDF) |
| 144 | Proteinase-Activated Receptors 2011, , 3095-3096 | | 4 | Citations (PDF) |
| 145 | Histamine and Antihistamines in Atopic Dermatitis | 0.0 | 44 | Citations (PDF) |
| 146 | Contribution of bone marrow-derived cells to the pro-inflammatory effects of protease-activated receptor-2 in colitis | 4.7 | 18 | Citations (PDF) |
| 147 | Erythema leprosum – after treatment of Lepromatous Leprosy | 0.6 | 2 | Citations (PDF) |
| 148 | Interferon‐γ induces upregulation and activation of the interleukin‐31 receptor in human dermal microvascular endothelial cells | 2.8 | 11 | Citations (PDF) |
| 149 | Livedoid Vasculopathy in a Pediatric Patient With Elevated Lipoprotein(a) Levels: Prompt Response to Continuous Low-Molecular-Weight Heparin | 2.2 | 41 | Citations (PDF) |
| 150 | Par2 Inactivation Inhibits Early Production of TSLP, but Not Cutaneous Inflammation, in Netherton Syndrome Adult Mouse Model | 0.7 | 88 | Citations (PDF) |
| 151 | Innovative Management of Pruritus | 2.0 | 25 | Citations (PDF) |
| 152 | Preliminary evidence for a role of mast cells in epidermal growth factor receptor inhibitor–induced pruritus | 1.3 | 35 | Citations (PDF) |
| 153 | Pituitary Adenylate Cyclase Activating Polypeptide | 3.6 | 60 | Citations (PDF) |
| 154 | Inflammation 2010, , 1-76 | | 1 | Citations (PDF) |
| 155 | Endosomal Endothelin-converting Enzyme-1 | 2.3 | 58 | Citations (PDF) |
| 156 | Thrombin receptor: An endogenous inhibitor of inflammatory pain, activating opioid pathways | 4.6 | 39 | Citations (PDF) |
| 157 | A TR(I)P to Pruritus Research: Role of TRPV3 in Inflammation and Itch | 0.7 | 55 | Citations (PDF) |
| 158 | Role of Matriptase and Proteinase-Activated Receptor-2 in Nonmelanoma Skin Cancer | 0.7 | 38 | Citations (PDF) |
| 159 | Topical Immunomodulators 2009, , 417-436 | | 0 | Citations (PDF) |
| 160 | Intracellular degradation of somatostatin‐14 following somatostatin‐receptor 3‐mediated endocytosis in rat insulinoma cells | 5.5 | 7 | Citations (PDF) |
| 161 | “Outside-to-Inside” (and Now Back to “Outside”) Pathogenic Mechanisms in Atopic Dermatitis | 0.7 | 232 | Citations (PDF) |
| 162 | Activation of Proteinase-Activated Receptor-2 by Human Kallikrein-Related Peptidases | 0.7 | 149 | Citations (PDF) |
| 163 | Protease-activated receptor-2 activation: a major actor in intestinal inflammation | 14.8 | 89 | Citations (PDF) |
| 164 | Calcineurin inhibitors for the treatment of atopic dermatitis | 2.3 | 9 | Citations (PDF) |
| 165 | Agonists of Proteinase-Activated Receptor-2 Enhance IFN-γ-Inducible Effects on Human Monocytes: Role in Influenza A Infection | 0.6 | 20 | Citations (PDF) |
| 166 | Endothelin-Converting Enzyme-1 Degrades Internalized Somatostatin-14 | 2.7 | 30 | Citations (PDF) |
| 167 | Proteinase-activated receptor-2 in the skin: Receptor expression,
activation and function during health and disease | 2.7 | 57 | Citations (PDF) |
| 168 | Topical calcineurin inhibitors | 0.0 | 2 | Citations (PDF) |
| 169 | Itch – pathophysiology and treatment | 0.0 | 0 | Citations (PDF) |
| 170 | Topical Immune Response Modifiers: Antiinflammatories 2008, , 539-549 | | 0 | Citations (PDF) |
| 171 | Endothelin-converting enzyme-1 regulates endosomal sorting of calcitonin receptor-like receptor and β-arrestins | 4.8 | 84 | Citations (PDF) |
| 172 | Agonist-Induced Endocytosis of Rat Somatostatin Receptor 1 | 2.7 | 11 | Citations (PDF) |
| 173 | Tumor immune escape by the loss of homeostatic chemokine expression | 7.7 | 116 | Citations (PDF) |
| 174 | Post-endocytic Sorting of Calcitonin Receptor-like Receptor and Receptor Activity-modifying Protein 1 | 2.3 | 63 | Citations (PDF) |
| 175 | Neuroimmune interactions in allergic skin diseases | 2.6 | 40 | Citations (PDF) |
| 176 | Protease-activated receptors: novel PARtners in innate immunity | 15.9 | 85 | Citations (PDF) |
| 177 | Successful treatment of generalized eruptive histiocytoma with PUVA | 0.6 | 16 | Citations (PDF) |
| 178 | Endothelin-converting enzyme 1 degrades neuropeptides in endosomes to control receptor recycling | 7.7 | 72 | Citations (PDF) |
| 179 | Microfluidic reveals generation of platelet-strings on tumoractivated endothelium | 4.4 | 47 | Citations (PDF) |
| 180 | Evaluation of protease-activated receptor 2 in murine models of arthritis | 7.3 | 63 | Citations (PDF) |
| 181 | Intermedin: A Skin Peptide that Is Downregulated in Atopic Dermatitis | 0.7 | 8 | Citations (PDF) |
| 182 | Proteinase-Activated Receptor-2 (PAR2): A Tumor Suppressor in Skin Carcinogenesis | 0.7 | 43 | Citations (PDF) |
| 183 | Agonists of proteinase‐activated receptor‐2 affect transendothelial migration and apoptosis of human neutrophils | 2.8 | 27 | Citations (PDF) |
| 184 | Role for protease activity in visceral pain in irritable bowel syndrome | 9.1 | 472 | Citations (PDF) |
| 185 | Protease-Activated Receptor-2 Activation | 3.6 | 94 | Citations (PDF) |
| 186 | IL-31: A new link between T cells and pruritus in atopic skin inflammation | 2.8 | 777 | Citations (PDF) |
| 187 | Cytokines and chemokines orchestrate atopic skin inflammation | 2.8 | 454 | Citations (PDF) |
| 188 | Role of vasculature in atopic dermatitis | 2.8 | 41 | Citations (PDF) |
| 189 | Neurogenic components of trypsin‐ and thrombin‐induced inflammation in rat skin, <i>in vivo</i> | 2.8 | 23 | Citations (PDF) |
| 190 | Persistierende Plaques am Rucken und rechten Oberam | 0.6 | 0 | Citations (PDF) |
| 191 | The neurobiology of itch | 10.0 | 816 | Citations (PDF) |
| 192 | Functional Characterization and Expression Analysis of the Proteinase-Activated Receptor-2 in Human Cutaneous Mast Cells | 0.7 | 90 | Citations (PDF) |
| 193 | Neurophysiological, Neuroimmunological, and Neuroendocrine Basis of Pruritus | 0.7 | 202 | Citations (PDF) |
| 194 | Molekulare Mechanismen der kutanen neurogenen Entzündung und des Juckreizes | 0.0 | 0 | Citations (PDF) |
| 195 | Tumor-Derived Matrix Metalloproteinase-1 Targets Endothelial Proteinase-Activated Receptor 1 Promoting Endothelial Cell Activation | 0.6 | 120 | Citations (PDF) |
| 196 | Neuronal Control of Skin Function: The Skin as a Neuroimmunoendocrine Organ | 26.6 | 501 | Citations (PDF) |
| 197 | Ubiquitin-dependent Down-regulation of the Neurokinin-1 Receptor | 2.3 | 55 | Citations (PDF) |
| 198 | A role for proteinase-activated receptor-1 in inflammatory bowel diseases | 9.1 | 5 | Citations (PDF) |
| 199 | Frontiers in pruritus research: scratching the brain for more effective itch therapy | 9.1 | 291 | Citations (PDF) |
| 200 | Tumor-Endothelial MMP1/PAR1 Crosstalk Promotes Formation of UL-VWF-Strings on Human Endothelium.Blood, 2006, 108, 3945-3945 | 1.0 | 0 | Citations (PDF) |
| 201 | Proteinase-activated Receptor-1 is an Anti-Inflammatory Signal for Colitis Mediated by a Type 2 Immune Response | 2.4 | 54 | Citations (PDF) |
| 202 | Pathway management in ambulatory wound care: defining local standards for quality improvement and interprofessional care | 3.2 | 8 | Citations (PDF) |
| 203 | Agonists of Proteinase-Activated Receptor-2 Stimulate Upregulation of Intercellular Cell Adhesion Molecule-1 in Primary Human Keratinocytes via Activation of NF-kappa B | 0.7 | 108 | Citations (PDF) |
| 204 | Viewpoint 5 | 2.8 | 3 | Citations (PDF) |
| 205 | Stimulation of keratinocyte differentiation - a new role for the vanilloid receptor subtype 1 (VR1/TRPV1)? | 2.8 | 4 | Citations (PDF) |
| 206 | Proteinase-Activated Receptors: Transducers of Proteinase-Mediated Signaling in Inflammation and Immune Response | 26.0 | 447 | Citations (PDF) |
| 207 | Cutaneous allergic contact dermatitis responses are diminished in mice deficient in neurokinin 1 receptors and augmented by neurokinin 2 receptor blockage | 0.7 | 45 | Citations (PDF) |
| 208 | Recycling and Resensitization of the Neurokinin 1 Receptor | 2.3 | 74 | Citations (PDF) |
| 209 | Expression of vanilloid receptor subtype 1 in cutaneous sensory nerve fibers, mast cells, and epithelial cells of appendage structures | 2.8 | 359 | Citations (PDF) |
| 210 | Anti-inflammatory effects of nitric oxide-releasing hydrocortisone NCX 1022, in a murine model of contact dermatitis | 6.5 | 36 | Citations (PDF) |
| 211 | A role for proteinase-activated receptor–1 in inflammatory bowel diseases | 9.1 | 76 | Citations (PDF) |
| 212 | Role of proteinase-activated receptors in cutaneous biology and disease | 3.5 | 21 | Citations (PDF) |
| 213 | Pruritus - Pathophysiologie, Klinik und Therapie - Eine Ubersicht. Pruritus - pathophysiology, clinical features and therapy - an overview | 0.6 | 29 | Citations (PDF) |
| 214 | Proteinase-activated receptors: novel signals for peripheral nerves | 13.4 | 104 | Citations (PDF) |
| 215 | Colitis induced by proteinase-activated receptor-2 agonists is mediated by a neurogenic mechanism | 1.9 | 84 | Citations (PDF) |
| 216 | Modern Aspects of Cutaneous Neurogenic Inflammation | 2.2 | 265 | Citations (PDF) |
| 217 | Neurophysiology of Pruritus | 2.2 | 167 | Citations (PDF) |
| 218 | Proinflammatory role of proteinase‐activated receptor‐2 in humans and mice during cutaneous inflammation in vivo | 0.7 | 109 | Citations (PDF) |
| 219 | Neuronal Sensitization for Histamine-Induced Itch in Lesional Skin of Patients With Atopic Dermatitis | 2.2 | 97 | Citations (PDF) |
| 220 | Neurophysiology of Pruritus | 2.2 | 86 | Citations (PDF) |
| 221 | Proteinase-Activated Receptor-2 Mediates Itch: A Novel Pathway for Pruritus in Human Skin | 3.7 | 525 | Citations (PDF) |
| 222 | Characterization of Thrombin-Induced Leukocyte Rolling and Adherence: A Potential Proinflammatory Role for Proteinase-Activated Receptor-4 | 0.6 | 144 | Citations (PDF) |
| 223 | Localization of μ-opioid receptor 1A on sensory nerve fibers in human skin | 1.5 | 87 | Citations (PDF) |
| 224 | Pathophysiology of pruritus in atopic dermatitis: an overview | 2.8 | 185 | Citations (PDF) |
| 225 | Agonists of Proteinase-Activated Receptor 2 Induce Cytokine Release and Activation of Nuclear Transcription Factor κB in Human Dermal Microvascular Endothelial Cells | 0.7 | 107 | Citations (PDF) |
| 226 | Indirect RT–PCR in-situ hybridization: a novel non-radioactive method for detecting glucose-dependent insulinotropic peptide | 1.5 | 4 | Citations (PDF) |
| 227 | Keratinocytes in epidermal immune responses | 2.6 | 24 | Citations (PDF) |
| 228 | Agonists of proteinase-activated receptor 1 induce plasma extravasation by a neurogenic mechanism | 6.5 | 124 | Citations (PDF) |
| 229 | Neutral Endopeptidase Terminates Substance P-Induced Inflammation in Allergic Contact Dermatitis | 0.6 | 93 | Citations (PDF) |
| 230 | Keratinocytes in epidermal immune responses | 2.6 | 49 | Citations (PDF) |
| 231 | Presence and Bronchomotor Activity of Protease-Activated Receptor-2 in Guinea Pig Airways | 9.7 | 102 | Citations (PDF) |
| 232 | Agonists of proteinase-activated receptor 2 induce inflammation by a neurogenic mechanism | 25.6 | 836 | Citations (PDF) |
| 233 | Identification of pituitary adenylate cyclase activating polypeptide (PACAP) and PACAP type 1 receptor in human skin: expression of PACAP-38 is increased in patients with psoriasis | 1.5 | 38 | Citations (PDF) |
| 234 | Basolateral proteinase‐activated receptor (PAR‐2) induces chloride secretion in M‐1 mouse renal cortical collecting duct cells | 3.2 | 66 | Citations (PDF) |
| 235 | Trypsin activates pancreatic duct epithelial cell ion channels through proteinase-activated receptor-2 | 9.1 | 156 | Citations (PDF) |
| 236 | Neuropeptide regulation of human dermal microvascular endothelial cell ICAM-1 expression and function | 4.4 | 63 | Citations (PDF) |
| 237 | Proteinase-activated receptors: novel mechanisms of signaling by serine proteases | 4.4 | 679 | Citations (PDF) |
| 238 | Arguments against the prostatic origin of the R-3327 Dunning H tumor | 0.0 | 15 | Citations (PDF) |
| 239 | Basal cells of H-Dunning tumor are myoepithelial cells | 2.0 | 17 | Citations (PDF) |
